C37
Conditions
Interventions
Group 1: R0 Patients who have undergone surgery without adjuvant radiation therapy are compared with R0 patients who have undergone surgery with adjuvant radiation therapy. The surgery therefore takes
Sponsors
universitätsklinikum Freiburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with thymoma, neuroendocrine thymic tumor, thymic carcinoma, histologically determined Surgery with RO resection of the tumor Postoperative radiation therapy (PORT) and no PORT The following classifications are available: WHO subtype classification, Masaoka-Koga classification, TNM classification for tumor available, with only Masaoka-Koga classification stages 1-3 considered
Exclusion criteria
Exclusion criteria: Surgery with R1/R2 tumor residue Neoadjuvant or palliative radiation therapy Direct evidence of distant metastases Severe concomitant medical conditions or other contraindications for PORT
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival, disease progression, local recurrence. Fulfilled if number is given in months and indicate whether there was local recurrence or progression of the disease. Survey via Excel. | — |
Countries
Austria, France, Germany, Italy, Netherlands, Switzerland, United Kingdom, United States
Contacts
Public ContactAndreas Rimner
Universitätsklinikum Freiburg
Outcome results
None listed